日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

在接受tisagenlecleucel治疗前进行改良的淋巴清除能否改善高危大B细胞淋巴瘤患者的预后?

Canelo-Vilaseca, Marta; Sabbah, Mohamad; Cristinelli, Caterina; Bommier, Côme; Sesques, Pierre; Roussel, Mikael; Bories, Pierre; Allain, Vincent; Ouedrani, Amani; De Bernardis, Ilenia; Vely, Agathe; Stephan, Pierre; Vercellino, Laetitia; Venet, Fabienne; Pescarmona, Rémi; Houot, Roch; Vergez, François; de Jorna, Romain; Madelaine, Isabelle; Parquet, Nathalie; Brignier, Anne C; Larghero, Jérôme; Mebarki, Miryam; Di Blasi, Roberta; Caillat-Zucman, Sophie; Thieblemont, Catherine

Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

更正:在接受 tisagenlecleucel 治疗前进行改良的淋巴清除能否改善高危大 B 细胞淋巴瘤患者的预后?

Canelo-Vilaseca, Marta; Sabbah, Mohamad; Cristinelli, Caterina; Bommier, Côme; Sesques, Pierre; Roussel, Mikael; Bories, Pierre; Allain, Vincent; Ouedrani, Amani; De Bernardis, Ilenia; Vely, Agathe; Stephan, Pierre; Vercellino, Laetitia; Venet, Fabienne; Pescarmona, Rémi; Houot, Roch; Vergez, François; de Jorna, Romain; Madelaine, Isabelle; Parquet, Nathalie; Brignier, Anne C; Larghero, Jérôme; Mebarki, Miryam; Di Blasi, Roberta; Caillat-Zucman, Sophie; Thieblemont, Catherine

Burnout symptoms among hematology professionals: An EHA survey

血液科专业人员的职业倦怠症状:一项欧洲血液学协会(EHA)调查

Bommier, Côme; Perolla, Adela; Zelić Kerep, Ana; Irimia, Ruxandra; Iatrou, Nikolia; Macintyre, Elizabeth; Borges, Nuno

Erratum to: Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study

更正:苯达莫司汀和利妥昔单抗作为症状性脾边缘区淋巴瘤的一线治疗:BRISMA/IELSG36 II期研究的长期疗效和早期不可测量微小残留病灶达到的影响

Iannitto, Emilio; Ferrero, Simone; Bommier, Côme; Drandi, Daniela; Ferrante, Martina; Bouabdallah, Krimo; Carras, Sylvain; Gini, Guido; Camus, Vincent; Mancuso, Salvatrice; Marcheselli, Luigi; Ferrari, Angela; Merli, Michele; Tessoulin, Benoit; Stelitano, Caterina; Beldjord, Kheira; Roti, Giovanni; Jardin, Fabrice; Castagnari, Barbara; Palombi, Francesca; Baseggio, Lucile; Traverse-Glehen, Alexandra; Tripodo, Claudio; Liberati, Anna Marina; Parolini, Margherita; Usai, Sara; Patti, Caterina; Federico, Massimo; Musso, Maurizio; Ladetto, Marco; Zucca, Emanuele; Thieblemont, Catherine

Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study

左乙拉西坦常规预防在CD19 CAR-T治疗LBCL中并无益处:一项多中心倾向性匹配研究

Galli, Eugenio; Di Blasi, Roberta; Di Rocco, Alice; Cristinelli, Caterina; Pansini, Ilaria; Bommier, Côme; Corrente, Alessandro; De Bernardis, Ilenia; Viscovo, Marcello; Hohaus, Stefan; Modoni, Anna; Sorà, Federica; Chiusolo, Patrizia; Martelli, Maurizio; Sica, Simona; Thieblemont, Catherine

Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T

虚弱并非失败:合并症对接受 CAR-T 疗法治疗的 LBCL 患者的非复发死亡率和安全性影响有限

Galli, Eugenio; Di Blasi, Roberta; Pansini, Ilaria; Cristinelli, Caterina; Bommier, Come; De Bernardis, Ilenia; Corrente, Alessandro; Viscovo, Marcello; Montini, Luca; Chiusolo, Patrizia; Hohaus, Stefan; Sorà, Federica; Thieblemont, Catherine; Sica, Simona

Cross-referencing French hematology teams' knowledge and perception of end-of-life situations: a national mixed-methods survey

一项全国性混合方法调查:比较法国血液科团队对临终关怀情况的知识和看法

Prod'homme, Chloé; Bommier, Côme; Fenwarth, Laurène; Moreau, Stephane; Polomeni, Alice

Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment

边缘区淋巴瘤国际预后指数:一种适用于需要全身治疗的边缘区淋巴瘤的统一预后指数

Arcaini, Luca; Bommier, Côme; Alderuccio, Juan Pablo; Merli, Michele; Fabbri, Nicole; Nizzoli, Maria Elena; Maurer, Matthew J; Tarantino, Vittoria; Ferrero, Simone; Rattotti, Sara; Talami, Annalisa; Murru, Roberta; Khurana, Arushi; Mwangi, Raphael; Deodato, Marina; Cencini, Emanuele; Re, Francesca; Visco, Carlo; Feldman, Andrew L; Link, Brian K; Delamain, Marcia Torresan; Spina, Michele; Annibali, Ombretta; Pulsoni, Alessandro; Ferreri, Andrés J M; Stelitano, Caterina Cecilia; Pennese, Elsa; Habermann, Thomas M; Marcheselli, Luigi; Han, Sunwoo; Reis, Isildinha M; Paulli, Marco; Lossos, Izidore S; Cerhan, James R; Luminari, Stefano

Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study

苯达莫司汀和利妥昔单抗作为症状性脾边缘区淋巴瘤的一线治疗:BRISMA/IELSG36 II期研究的长期疗效及早期不可测量微小残留病灶达到的影响

Iannitto, Emilio; Ferrero, Simone; Bommier, Côme; Drandi, Daniela; Ferrante, Martina; Bouabdallah, Krimo; Carras, Sylvain; Gini, Guido; Camus, Vincent; Mancuso, Salvatrice; Marcheselli, Luigi; Ferrari, Angela; Merli, Michele; Tessoulin, Benoit; Stelitano, Caterina; Beldjord, Kheira; Roti, Giovanni; Jardin, Fabrice; Castagnari, Barbara; Palombi, Francesca; Baseggio, Lucile; Traverse-Glehen, Alexandra; Tripodo, Claudio; Liberati, Anna Marina; Parolini, Margherita; Usai, Sara; Patti, Caterina; Federico, Massimo; Musso, Maurizio; Ladetto, Marco; Zucca, Emanuele; Thieblemont, Catherine

Transformation of marginal zone lymphoma to Hodgkin lymphoma

边缘区淋巴瘤向霍奇金淋巴瘤的转化

Moalem, Kamilia N; Alderuccio, Juan Pablo; Bommier, Côme; Habermann, Thomas; Link, Brian K; Cerhan, James R; Florindez, Jorge; Lossos, Izidore S